| HOME >> BIOLOGY >> TECHNOLOGY |
Restructuring and Other Costs, Net
(d) 42.2 0.4% 45.7 1.2%
Equity Compensation Acceleration
Charges (e) - 0.0% 36.7 1.0%
Amortization of Acquisition-related
Intangible Assets 571.1 5.9% 170.8 4.5%
Amortization of Acquisition-related
Intangible Assets - Equity
Investments 1.5 0.0% - 0.0%
Loss on Extinguishment of Debt
Facilities (f) - 0.0% 0.9 0.0%
Other Income, Net (g) 4.5 0.1% - 0.0%
Provision for Income Taxes (h) (270.7) -2.8% (110.5) -2.9%
Discontinued Operations, Net of Tax 18.5 0.2% (2.6) -0.1%
Adjusted Net Income (b) $1,177.4 12.1% $387.6 10.2%
Reconciliation of Adjusted Earnings
per Share
GAAP EPS (a) $1.72 $0.84
Cost of Revenues Charges, Net of
Tax (c) 0.07 0.23
Restructuring and Other Costs, Net
of Tax (d) 0.06 0.18
Equity Compensation Acceleration
Charge, Net of Tax (e) - 0.12
Amortization of Acquisition-related
Intangible Assets, Net of Tax 0.82 0.54
Amortization of Acquisition-related
Intangible Assets, Net of Tax -
Equity Investments - -
Loss on Extinguishment of Debt
Facilities (f) - 0.01
Other Income, Net of Tax (g) 0.01 -
Provision for Income Taxes (h) (0.07) -
Discontinued Operations, Net of T
'/>"/>
| SOURCE Thermo Fisher Scientific Inc. Copyright©2008 PR Newswire. All rights reserved |